DEMARZO, MARIA GIULIA
DEMARZO, MARIA GIULIA
100007 - Dipartimento di Medicina interna e specialità mediche
A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease
2019-01-01 Bodini, Giorgia; Zanella, Claudia; Crespi, Mattia; Lo Pumo, Sara; Demarzo, Maria Giulia; Savarino, Edoardo; Savarino, Vincenzo; Giannini, Edoardo G
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator
2021-01-01 Cingolani, Linda; Barberio, Brigida; Zingone, Fabiana; Ferronato, Antonio; Bertani, Lorenzo; Costa, Francesco; Bodini, Giorgia; Demarzo, Maria Giulia; Melatti, Piera; Gubbiotti, Alessandro; Massimi, Davide; Casadei, Cesare; D'Incà, Renata; Savarino, Edoardo Vincenzo
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders
2021-01-01 Savarino, V.; Antonioli, L.; Fornai, M.; Marabotto, E.; Demarzo, M. G.; Zingone, F.; Ghisa, M.; Barberio, B.; Zentilin, P.; Ribolsi, M.; Savarino, E.
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation
2020-01-01 Giannini, Edoardo G.; Crespi, Mattia; Djahandideh, Afscin; Demarzo, Maria Giulia; Moscatelli, Alessandro; Bodini, Giorgia; Furnari, Manuele; Marabotto, Elisa; Plaz Torres, Maria Corina; Zentilin, Patrizia; Savarino, Vincenzo
Concerns related to COVID-19 pandemic among patients with Inflammatory Bowel Disease, and its influence on patients management
2020-01-01 Bodini, Giorgia; Demarzo, Maria Giulia; Casagrande, Edoardo; De Maria, Costanza; Kayali, Stefano; Ziola, Sebastiano; Giannini, Edoardo G
Elevated adherence to vaccination against SARS-CoV-2 among patients with Inflammatory Bowel Disease
2021-01-01 Giannini, Edoardo G; Demarzo, Maria Giulia; Bodini, Giorgia
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease
2019-01-01 Bodini, Giorgia; Demarzo, MARIA GIULIA; Saracco, Margherita; Coppo, Claudia; DE MARIA, Costanza; Baldissarro, Isabella; Savarino, Edoardo; Savarino, Vincenzo; Giannini, Edoardo G
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals
2019-01-01 Giannini, Edoardo G; Crespi, Mattia; Demarzo, Mariagiulia; Bodini, Giorgia; Furnari, Manuele; Marabotto, Elisa; Torre, Francesco; Zentilin, Patrizia; Savarino, Vincenzo
Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals
2018-01-01 Crespi, M; Demarzo, Mg; Brunacci, M; Pellegatta, G; Ferrando, F; Ballestrero, A; Grillo, F; Savarino, V; Giannini, Eg
Letter: vedolizumab or a second anti-TNF-no difference in efficacy for primary biologic failures with IBD
2021-01-01 Demarzo, Maria Giulia; Bodini, Giorgia; Vanello, Mattia; Martini, Martina; Giannini, Edoardo G
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio
In corso di stampa Costa, Francesco; Savarino, Edoardo; Bodini, Giorgia; Marchi, Santino; Bellini, Massimo; de Bortoli, Nicola; Brombin, Chiara; Mumolo, Maria Gloria; Ceccarelli, Linda; Baiano Svizzero, Giovanni; Albano, Eleonora; Tapete, Gherardo; Demarzo, Maria Giulia; Barberio, Brigida; Rossari, Federico; Bertani, Lorenzo
Pharmacological management of gastro-esophageal reflux disease: An update of the state-of-the-art
2021-01-01 Savarino, V.; Marabotto, E.; Zentilin, P.; Demarzo, M. G.; De Bortoli, N.; Savarino, E.
Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission
2023-01-01 Bodini, Giorgia; Ghezzi, Andrea; Pasta, Andrea; Marabotto, Elisa; Calabrese, Francesco; Facchini, Chiara; Demarzo, Maria Giulia; Giannini, Edoardo Giovanni
Reduction of fecal calprotectin levels induced by a short-course of Escherichia coli Nissle is associated with a lower likelihood of disease flares in patients with ulcerative colitis in clinical remission
2024-05-28 Demarzo, MARIA GIULIA
Regression of Fibrosis After DAAs Treatment of Patients with HCV Cirrhosis: Transposability to Non-Decompensated Patients
2019-01-01 Giannini, Edoardo G.; Crespi, Mattia; Demarzo, Mariagiulia; Bodini, Giorgia; Furnari, Manuele; Marabotto, Elisa; Torre, Francesco
Reproducibility and transportability of the absence of incremental infectious adverse events in patients with higher anti-TNF drug levels
2019-01-01 Giannini, Eg; Demarzo, MARIA GIULIA; Bodini, G
Response to COVID-19 Vaccination in Patients with Inflammatory Bowel Disease on Biological Treatment
2022-01-01 Bodini, Giorgia; Giuliana, Elisabetta; Giberti, Irene; Guarona, Giulia; Benvenuto, Federica; Ferretti, Elisa; Demarzo, Maria Giulia; Da Rin, Giorgio; Icardi, Giancarlo; Giannini, Edoardo G.
Review article – esophageal reflux hypersensitivity: Non-GERD or still GERD?
2020-01-01 Savarino, V.; Marabotto, E.; Zentilin, P.; Demarzo, M. G.; Pellegatta, G.; Frazzoni, M.; De Bortoli, N.; Tolone, S.; Giannini, E. G.; Savarino, E.
Therapeutic drug monitoring in Crohn's disease patients treated with anti-TNF: a comparison of two techniques
2022-01-01 Bodini, Giorgia; Demarzo, Maria Giulia; Djahandideh, Afscin; Ziola, Sebastiano; Risso, Paolo; Bertani, Lorenzo; Baldissarro, Isabella; Testa, Tommaso; Marchi, Santino; Savarino, Edoardo; Giannini, Edoardo Giovanni
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease | 1-gen-2019 | Bodini, Giorgia; Zanella, Claudia; Crespi, Mattia; Lo Pumo, Sara; Demarzo, Maria Giulia; Savarino, Edoardo; Savarino, Vincenzo; Giannini, Edoardo G | |
| Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator | 1-gen-2021 | Cingolani, Linda; Barberio, Brigida; Zingone, Fabiana; Ferronato, Antonio; Bertani, Lorenzo; Costa, Francesco; Bodini, Giorgia; Demarzo, Maria Giulia; Melatti, Piera; Gubbiotti, Alessandro; Massimi, Davide; Casadei, Cesare; D'Incà, Renata; Savarino, Edoardo Vincenzo | |
| An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders | 1-gen-2021 | Savarino, V.; Antonioli, L.; Fornai, M.; Marabotto, E.; Demarzo, M. G.; Zingone, F.; Ghisa, M.; Barberio, B.; Zentilin, P.; Ribolsi, M.; Savarino, E. | |
| Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation | 1-gen-2020 | Giannini, Edoardo G.; Crespi, Mattia; Djahandideh, Afscin; Demarzo, Maria Giulia; Moscatelli, Alessandro; Bodini, Giorgia; Furnari, Manuele; Marabotto, Elisa; Plaz Torres, Maria Corina; Zentilin, Patrizia; Savarino, Vincenzo | |
| Concerns related to COVID-19 pandemic among patients with Inflammatory Bowel Disease, and its influence on patients management | 1-gen-2020 | Bodini, Giorgia; Demarzo, Maria Giulia; Casagrande, Edoardo; De Maria, Costanza; Kayali, Stefano; Ziola, Sebastiano; Giannini, Edoardo G | |
| Elevated adherence to vaccination against SARS-CoV-2 among patients with Inflammatory Bowel Disease | 1-gen-2021 | Giannini, Edoardo G; Demarzo, Maria Giulia; Bodini, Giorgia | |
| High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease | 1-gen-2019 | Bodini, Giorgia; Demarzo, MARIA GIULIA; Saracco, Margherita; Coppo, Claudia; DE MARIA, Costanza; Baldissarro, Isabella; Savarino, Edoardo; Savarino, Vincenzo; Giannini, Edoardo G | |
| Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals | 1-gen-2019 | Giannini, Edoardo G; Crespi, Mattia; Demarzo, Mariagiulia; Bodini, Giorgia; Furnari, Manuele; Marabotto, Elisa; Torre, Francesco; Zentilin, Patrizia; Savarino, Vincenzo | |
| Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals | 1-gen-2018 | Crespi, M; Demarzo, Mg; Brunacci, M; Pellegatta, G; Ferrando, F; Ballestrero, A; Grillo, F; Savarino, V; Giannini, Eg | |
| Letter: vedolizumab or a second anti-TNF-no difference in efficacy for primary biologic failures with IBD | 1-gen-2021 | Demarzo, Maria Giulia; Bodini, Giorgia; Vanello, Mattia; Martini, Martina; Giannini, Edoardo G | |
| Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio | In corso di stampa | Costa, Francesco; Savarino, Edoardo; Bodini, Giorgia; Marchi, Santino; Bellini, Massimo; de Bortoli, Nicola; Brombin, Chiara; Mumolo, Maria Gloria; Ceccarelli, Linda; Baiano Svizzero, Giovanni; Albano, Eleonora; Tapete, Gherardo; Demarzo, Maria Giulia; Barberio, Brigida; Rossari, Federico; Bertani, Lorenzo | |
| Pharmacological management of gastro-esophageal reflux disease: An update of the state-of-the-art | 1-gen-2021 | Savarino, V.; Marabotto, E.; Zentilin, P.; Demarzo, M. G.; De Bortoli, N.; Savarino, E. | |
| Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission | 1-gen-2023 | Bodini, Giorgia; Ghezzi, Andrea; Pasta, Andrea; Marabotto, Elisa; Calabrese, Francesco; Facchini, Chiara; Demarzo, Maria Giulia; Giannini, Edoardo Giovanni | |
| Reduction of fecal calprotectin levels induced by a short-course of Escherichia coli Nissle is associated with a lower likelihood of disease flares in patients with ulcerative colitis in clinical remission | 28-mag-2024 | Demarzo, MARIA GIULIA | |
| Regression of Fibrosis After DAAs Treatment of Patients with HCV Cirrhosis: Transposability to Non-Decompensated Patients | 1-gen-2019 | Giannini, Edoardo G.; Crespi, Mattia; Demarzo, Mariagiulia; Bodini, Giorgia; Furnari, Manuele; Marabotto, Elisa; Torre, Francesco | |
| Reproducibility and transportability of the absence of incremental infectious adverse events in patients with higher anti-TNF drug levels | 1-gen-2019 | Giannini, Eg; Demarzo, MARIA GIULIA; Bodini, G | |
| Response to COVID-19 Vaccination in Patients with Inflammatory Bowel Disease on Biological Treatment | 1-gen-2022 | Bodini, Giorgia; Giuliana, Elisabetta; Giberti, Irene; Guarona, Giulia; Benvenuto, Federica; Ferretti, Elisa; Demarzo, Maria Giulia; Da Rin, Giorgio; Icardi, Giancarlo; Giannini, Edoardo G. | |
| Review article – esophageal reflux hypersensitivity: Non-GERD or still GERD? | 1-gen-2020 | Savarino, V.; Marabotto, E.; Zentilin, P.; Demarzo, M. G.; Pellegatta, G.; Frazzoni, M.; De Bortoli, N.; Tolone, S.; Giannini, E. G.; Savarino, E. | |
| Therapeutic drug monitoring in Crohn's disease patients treated with anti-TNF: a comparison of two techniques | 1-gen-2022 | Bodini, Giorgia; Demarzo, Maria Giulia; Djahandideh, Afscin; Ziola, Sebastiano; Risso, Paolo; Bertani, Lorenzo; Baldissarro, Isabella; Testa, Tommaso; Marchi, Santino; Savarino, Edoardo; Giannini, Edoardo Giovanni |